Genentech Financial Statements
Genentech Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Genentech Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 11,724.0 | 9,284.0 | 6,633.4 |
| Gross Profit ($ mil.) | 10,153.0 | 8,103.0 | 5,622.3 |
| Operating Income ($ mil.) | 4,229.0 | 3,152.0 | 1,921.8 |
| Total Net Income ($ mil.) | 2,769.0 | 2,113.0 | 1,279.0 |
| Diluted EPS (Net Income) | 2.59 | 1.97 | 1.18 |
Genentech Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,063.0 | 2,969.0 | 2,908.0 |
| Gross Profit ($ mil.) | 2,674.0 | 2,625.0 | 2,502.0 |
| Operating Income ($ mil.) | 1,519.0 | 985.0 | 1,061.0 |
| Total Net Income ($ mil.) | 983.0 | 631.0 | 685.0 |
| Diluted EPS (Net Income) | 0.92 | 0.59 | 0.64 |
Genentech Stock Quote & Chart
07/03/08 12:00:45 EST •
NYSE •
77.94
•
 -0.2000
•
-0.2560 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Genentech Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 6.40 | 3.77 | 1.54 |
| Price/Earnings Ratio | 25.16 | 15.99 | 15.14 |
| Price/Book Ratio | 5.83 | 2.70 | 1.46 |
| Price/Cash Flow Ratio | 22.03 | 11.60 | 9.41 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Genentech Financial Ratios
Genentech Competitive Intelligence
| Amgen | Bristol-Myers Squibb | GlaxoSmithKline | |
|---|---|---|---|
| Annual Sales ($ mil.) | 14,771.0 | 19,348.0 | 45,816.1 |
| Employees | 17,500 | 42,000 | -- |
| Market Cap ($ mil.) | 50,450.6 | 38,848.3 | -- |
Competitive Landscape
